YU YONG (VP, Clinical Trial Operations) received a stock award from GENELUX CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001493152-26-029414
Officer· VP, Clinical Trial Operations
Since Jan 2023
+119.32K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
119.32K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+119.32K
Price / share
—
Trade value
—
% of position
79.7%
6/16/2026
149.71K→269.02K
Total
Net shares
+119.32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | A · Award | +119.32K | — | — | 79.7% | 149.71K | 269.02K |
| Total | +119.32K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported